Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP1147462.RABrjqjDxmTcNJyHLFGHYvZheGv0I9PSfAyYwNxDxzF7I130_assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147462.RABrjqjDxmTcNJyHLFGHYvZheGv0I9PSfAyYwNxDxzF7I130_provenance.
• assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1147461.RA8DA52VywDraASJC2q22hxItZdAOOvPPuCz0EK6i2IgE130_assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147461.RA8DA52VywDraASJC2q22hxItZdAOOvPPuCz0EK6i2IgE130_provenance.
• NP1147463.RA1uiWF07ngheTBb6SSotWVoNRogNjhpkWqvo4c8KtZs8130_assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147463.RA1uiWF07ngheTBb6SSotWVoNRogNjhpkWqvo4c8KtZs8130_provenance.
• NP1147469.RA-tvAFsEv8DTgi679foIee69YILXFoEjmjLt3fLFciKY130_assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147469.RA-tvAFsEv8DTgi679foIee69YILXFoEjmjLt3fLFciKY130_provenance.
• NP1147473.RA7cOpsQ78gRJ--znzAT160nkeK0JuhVHwRXmYH6CMyT4130_assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147473.RA7cOpsQ78gRJ--znzAT160nkeK0JuhVHwRXmYH6CMyT4130_provenance.
• NP1147474.RA-HtbKGzZUi1AqLdH79ymgdOBTjSYVzE0S1YWxkNkAOs130_assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147474.RA-HtbKGzZUi1AqLdH79ymgdOBTjSYVzE0S1YWxkNkAOs130_provenance.
• assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1147464.RAEFCgcl_V3kD0T8-8w-s7BuoT2kbrEE2mwar39Os5_-g130_assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147464.RAEFCgcl_V3kD0T8-8w-s7BuoT2kbrEE2mwar39Os5_-g130_provenance.
• NP1147465.RAh1ADE-fGrBPADYB-oX-N2qeKM4gHV-1WH0Edg8vsEpU130_assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147465.RAh1ADE-fGrBPADYB-oX-N2qeKM4gHV-1WH0Edg8vsEpU130_provenance.
• NP1147470.RAtL1yWA8xu7BYZMeKH1Cq9rzkPVD2UAJ94GjfV9hSSEY130_assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147470.RAtL1yWA8xu7BYZMeKH1Cq9rzkPVD2UAJ94GjfV9hSSEY130_provenance.
• NP1147475.RAiCW7LizZwQA9TUuIbRDO6Lso3Hm36JzYS1WJQANNj3o130_assertion description "[Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1147475.RAiCW7LizZwQA9TUuIbRDO6Lso3Hm36JzYS1WJQANNj3o130_provenance.